articleCellDec 1, 2017BRONZE OA

Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy

Harvard University · Center for Systems Biology

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

660
total citations
FWCI
53.53
Percentile
100%
References
58
Citations per year

Authors

2

Topics & keywords

Keywords
  • Drug
  • Drug action
  • Clinical trial
  • Drug resistance
  • Biology
  • Combination therapy
  • Pharmacology
  • Mechanism (biology)
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding